JAK (Janus kinase) inhibitors in rheumatoid arthritis
JAK inhibitors, novel oral medications for rheumatoid arthritis, have shown superiority to standard-of-care treatments and provide rapid onset of pain relief
You will learn:
• Inflammatory pathway targets for the treatment of rheumatoid arthritis
• The mechanism of action of JAK inhibitors
• Clinical attributes of JAK inhibitors
• Current evidence on efficacy, versatility in dosing and treatment switching, and safety and tolerability of JAK inhibitors.
WEBINAR HELD ON 29 MARCH 2022.